查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球感染监测解决方案市场 - 全球规模、份额、趋势分析、机会和预测报告：按产品、按感染类型、按最终用途、按地区（2019-2029）
市场调查报告书
商品编码
1227631

全球感染监测解决方案市场 - 全球规模、份额、趋势分析、机会和预测报告：按产品、按感染类型、按最终用途、按地区（2019-2029）

Infection Surveillance Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Offering ; By Infection Type ; By End Use ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 478 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球感染监测解决方案市场规模预计到 2022 年为 46991 万美元，在 2023 年至 2029 年的预测期内以 13.81% 的复合年增长率显着增长，到 2029 年将达到 11 亿美元。预计将达到 52.12 美元百万。 推动市场增长的主要因素包括医院获得性感染 (HAI) 的流行、微生物中抗生素耐药性的增加以及医疗保健环境中自动化的高度采用。

本报告考察了全球感染监测解决方案市场，概述了市场、市场规模和预测、趋势、驱动因素和限制因素，并按产品、感染类型、最终用途和地区进行了细分。它提供了全面的信息例如分析和公司简介。

内容

第一章研究框架

第 2 章执行摘要

第 3 章全球感染监测解决方案市场洞察

  • 行业价值链分析
  • DROC 分析
    • 司机
      • 扩大采用抗菌管理计划
      • 汽车和运输行业的增长
    • 约束因素
      • 小型医疗机构的引入成本高
      • 隐私和安全问题
    • 机会
      • 医疗保健相关感染 (HAI) 发病率上升推动了对感染监测解决方案的需求
    • 任务
      • 有限的意识和教育
  • 技术进步/最新发展
  • 监管框架
  • 波特的五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争激烈程度

第 4 章全球感染监测解决方案市场概述

  • 市场规模和预测（2019-2029 年）
    • 按金额
  • 市场份额和预测
    • 通过报价
      • 软件
      • 服务
    • 按感染类型
      • 手术部位感染 (SSI)
      • 血流感染 (BSI)
      • 尿路感染 (UTI)
      • 其他
    • 按最终用途
      • 疗养院
      • 医院
      • 其他（诊所、门诊手术中心）
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲

第五章北美感染监测解决方案市场

  • 市场规模和预测（2019-2029 年）
    • 按金额
  • 市场份额和预测
    • 通过报价
    • 按感染类型
    • 按最终用途
    • 按国家
      • 美国
      • 加拿大

第 6 章：欧洲感染监测解决方案市场

  • 市场规模和预测（2019-2029 年）
    • 按金额
  • 市场份额和预测
    • 通过报价
    • 按感染类型
    • 按最终用途
    • 按国家
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 荷兰
      • 其他欧洲

第七章亚太感染监测解决方案市场

  • 市场规模和预测（2019-2029 年）
    • 按金额
  • 市场份额和预测
    • 通过报价
    • 按感染类型
    • 按最终用途
    • 按国家
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印度尼西亚
      • 马来西亚
      • 新加坡
      • 菲律宾
      • 越南
      • 亚太其他地区

第 8 章拉丁美洲的感染监测解决方案市场

  • 市场规模和预测（2019-2029 年）
    • 按金额
  • 市场份额和预测
    • 通过报价
    • 按感染类型
    • 按最终用途
    • 按国家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他拉丁美洲

第9章：中东和非洲的感染监测解决方案市场

  • 市场规模和预测（2019-2029 年）
    • 按金额
  • 市场份额和预测
    • 通过报价
    • 按感染类型
    • 按最终用途
    • 按国家
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • 其他中东和非洲地区

第10章竞争格局

  • 主要公司及其产品列表
  • 2022 年全球感染监测解决方案公司的市场份额分析
  • 按运营参数进行竞争性基准测试
  • 重大战略发展（合併、收购、合作等）

第 11 章 COVID-19 对全球感染监测解决方案市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争对手、联繫人、战略展望、SWOT分析）

  • 赛纳公司
  • 史诗系统公司
  • 维吉兰兹公司
  • Becton, Dickinson and Company
  • 总理公司
  • DEB 集团有限公司
  • 强化学习解决方案
  • 百特国际公司 (ICNet International)
  • Gojo 工业公司
  • IBM 公司（Truven 健康分析）
  • 其他有影响力的公司

第 13 章关键战略建议

第 14 章研究方法论

简介目录
Product Code: BWC23158

Global Infection Surveillance Solutions Market Size More Than Doubles to Touch USD 1.2 Billion by 2029.

Global infection surveillance solutions market is flourishing because of rising prevalence of hospital-acquired infections and high adoption of antimicrobial stewardship programs.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global infection surveillance solutions market size at USD 469.91 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global infection surveillance solutions market size to grow at a significant CAGR of 13.81% reaching a value of USD 1,152.12 million by 2029. Major growth factors for global infection surveillance solutions market include growing prevalence of hospital-acquired infections (HAIs), increasing antibiotic resistance in microorganisms, and high adoption of automation in healthcare settings. The growing number of procedures conducted around the world has resulted in longer hospital stays. As a result, the number of patients suffering from HAIs is expected to rise. The global market is expected to benefit from this trend. Increasing healthcare investments are also expected to spur the demand for infection surveillance technologies. Also, favorable government measures have contributed to the market expansion. However, high cost of deployment for small healthcare organizations and privacy and security concerns are anticipated to hinder the overall market growth.

Global Infection Surveillance Solutions Market - Overview:

Infection monitoring software supports healthcare facilities, such as hospitals, in reporting patient data to state and federal authorities. This program notifies hospital Internet Protocol (IPs) when an infection occurs, allowing HAI specialists and nurses to treat infected patients and prevent infection epidemics. These solutions are used to identify infections as well as to evaluate prevention actions. They are also required to avoid infections caused by sterilized medical devices and to diagnose antibiotic-resistant organisms. These systems benefit healthcare facilities by providing accurate staff health information, surgical databases, and real-time medical records. Surveillance strategies are employed to control infection patterns. The increasing analytics capabilities of IT systems is assisting the market's growth. Hospitals have emerged as the primary end-user in these sectors due to their high adoption rate for preserving electronic healthcare data and managing real-time pharmacy. Infection monitoring systems are meant to continuously monitor and analyze health-related data to ensure that preventive actions are properly applied. Hospital-acquired illnesses, also known as nosocomial infections, are caused by a variety of factors, including poor hygienic conditions, neglect, weakened patient immunity, the invasion of drug-resistant bacteria, and procedures that can reduce the effectiveness of ongoing treatments.

Impact of COVID-19 on Global Infection Surveillance Solutions Market

COVID-19 had a detrimental impact on infection surveillance solutions market. The pandemic compelled governments to invest extensively in vaccination efforts as well as hospital facilities and staffing. However, the global economic slump has upended government intentions to maintain or grow spending to address a backlog of non-COVID treatment and resolve staffing shortages. According to the Economist Intelligence Unit, total healthcare spending will rise by 4.9% in nominal terms in 2023, owing to higher expenses and wages. Yet, actual spending is anticipated to fall somewhat as it fails to keep up with inflation.

Global Infection Surveillance Solutions Market - By Offering:

By offering, global infection surveillance solutions market is bifurcated into Software and Services segments. The software segment is expected to hold a higher share in global infection surveillance solutions market during the forecast period because of the increasing use of management surveillance software. The software segment includes on-premises and web-based. During the projected period, the web-based software is expected to grow at a faster rate. The rise in sub-segment can be ascribed to its advantages over on-premises software, including as availability in various configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT businesses develop unique solutions in data management, analytics, and infrastructure that facilitate the collecting of data from electronic health records (EHR), infection, and epidemic patterns via their software packages.

Competitive Landscape:

Major players operating in global infection surveillance solutions market include: Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., and IBM Corporation (Truven Health Analytics). To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Infection Surveillance Solutions Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Infection Surveillance Solutions Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Infection Surveillance Solutions Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing Adoption of Antimicrobial Stewardship Programs
      • 3.2.1.2. Increasing Automotive and Transportation Industry
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Deployment for Small Healthcare Organizations
      • 3.2.2.2. Privacy and Security Concerns
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing incidences of Healthcare-Associated Infections (HAIs) Driving Demand for Infection Surveillance Solutions
    • 3.2.4. Challenges
      • 3.2.4.1. Limited Awareness and Education
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Infection Surveillance Solutions Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Offering
      • 4.2.1.1. Software
      • 4.2.1.1.1. On-premises
      • 4.2.1.1.2. Web-based
      • 4.2.1.2. Services
      • 4.2.1.2.1. Maintenance and Support
      • 4.2.1.2.2. Consultation and Training
      • 4.2.1.2.3. Implementation Service
    • 4.2.2. By Infection Type
      • 4.2.2.1. Surgical Site Infections (SSI)
      • 4.2.2.2. Blood Stream Infections (BSI)
      • 4.2.2.3. Urinary Tract Infections (UTI)
      • 4.2.2.4. Others
    • 4.2.3. By End Use
      • 4.2.3.1. Long Term Care Facilities
      • 4.2.3.2. Hospitals
      • 4.2.3.3. Others (Clinics, Ambulatory Surgical Centers)
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Infection Surveillance Solutions Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Offering
    • 5.2.2. By Infection Type
    • 5.2.3. By End Use
    • 5.2.4. By Country
      • 5.2.4.1. US
      • 5.2.4.1.1. By Offering
      • 5.2.4.1.2. By Infection Type
      • 5.2.4.1.3. By End Use
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Offering
      • 5.2.4.2.2. By Infection Type
      • 5.2.4.2.3. By End Use

6. Europe Infection Surveillance Solutions Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Offering
    • 6.2.2. By Infection Type
    • 6.2.3. By End Use
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Offering
      • 6.2.4.1.2. By Infection Type
      • 6.2.4.1.3. By End Use
      • 6.2.4.2. UK
      • 6.2.4.2.1. By Offering
      • 6.2.4.2.2. By Infection Type
      • 6.2.4.2.3. By End Use
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Offering
      • 6.2.4.3.2. By Infection Type
      • 6.2.4.3.3. By End Use
      • 6.2.4.4. France
      • 6.2.4.4.1. By Offering
      • 6.2.4.4.2. By Infection Type
      • 6.2.4.4.3. By End Use
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Offering
      • 6.2.4.5.2. By Infection Type
      • 6.2.4.5.3. By End Use
      • 6.2.4.6. The Netherlands
      • 6.2.4.6.1. By Offering
      • 6.2.4.6.2. By Infection Type
      • 6.2.4.6.3. By End Use
      • 6.2.4.7. Rest of Europe
      • 6.2.4.7.1. By Offering
      • 6.2.4.7.2. By Infection Type
      • 6.2.4.7.3. By End Use

7. Asia-Pacific Infection Surveillance Solutions Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Offering
    • 7.2.2. By Infection Type
    • 7.2.3. By End Use
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Offering
      • 7.2.4.1.2. By Infection Type
      • 7.2.4.1.3. By End Use
      • 7.2.4.2. India
      • 7.2.4.2.1. By Offering
      • 7.2.4.2.2. By Infection Type
      • 7.2.4.2.3. By End Use
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Offering
      • 7.2.4.3.2. By Infection Type
      • 7.2.4.3.3. By End Use
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Offering
      • 7.2.4.4.2. By Infection Type
      • 7.2.4.4.3. By End Use
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Offering
      • 7.2.4.5.2. By Infection Type
      • 7.2.4.5.3. By End Use
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Offering
      • 7.2.4.6.2. By Infection Type
      • 7.2.4.6.3. By End Use
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Offering
      • 7.2.4.7.2. By Infection Type
      • 7.2.4.7.3. By End Use
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Offering
      • 7.2.4.8.2. By Infection Type
      • 7.2.4.8.3. By End Use
      • 7.2.4.9. Philippines
      • 7.2.4.9.1. By Offering
      • 7.2.4.9.2. By Infection Type
      • 7.2.4.9.3. By End Use
      • 7.2.4.10. Vietnam
      • 7.2.4.10.1. By Offering
      • 7.2.4.10.2. By Infection Type
      • 7.2.4.10.3. By End Use
      • 7.2.4.11. Rest of APAC
      • 7.2.4.11.1. By Offering
      • 7.2.4.11.2. By Infection Type
      • 7.2.4.11.3. By End Use

8. Latin America Infection Surveillance Solutions Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Offering
    • 8.2.2. By Infection Type
    • 8.2.3. By End Use
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Offering
      • 8.2.4.1.2. By Infection Type
      • 8.2.4.1.3. By End Use
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Offering
      • 8.2.4.2.2. By Infection Type
      • 8.2.4.2.3. By End Use
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Offering
      • 8.2.4.3.2. By Infection Type
      • 8.2.4.3.3. By End Use
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Offering
      • 8.2.4.4.2. By Infection Type
      • 8.2.4.4.3. By End Use
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Offering
      • 8.2.4.5.2. By Infection Type
      • 8.2.4.5.3. By End Use

9. Middle East & Africa Infection Surveillance Solutions Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Offering
    • 9.2.2. By Infection Type
    • 9.2.3. By End Use
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Offering
      • 9.2.4.1.2. By Infection Type
      • 9.2.4.1.3. By End Use
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Offering
      • 9.2.4.2.2. By Infection Type
      • 9.2.4.2.3. By End Use
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Offering
      • 9.2.4.3.2. By Infection Type
      • 9.2.4.3.3. By End Use
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Offering
      • 9.2.4.4.2. By Infection Type
      • 9.2.4.4.3. By End Use
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Offering
      • 9.2.4.5.2. By Infection Type
      • 9.2.4.5.3. By End Use
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Offering
      • 9.2.4.6.2. By Infection Type
      • 9.2.4.6.3. By End Use
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Offering
      • 9.2.4.7.2. By Infection Type
      • 9.2.4.7.3. By End Use
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Offering
      • 9.2.4.8.2. By Infection Type
      • 9.2.4.8.3. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Infection Surveillance Solutions Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Infection Surveillance Solutions Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Cerner Corporation
  • 12.2. Epic Systems Corporation
  • 12.3. VigiLanz Corporation
  • 12.4. Becton, Dickinson and Company
  • 12.5. Premier Inc.
  • 12.6. DEB Group Ltd
  • 12.7. RL Solutions
  • 12.8. Baxter International Inc. (ICNet International)
  • 12.9. Gojo Industries Inc.
  • 12.10. IBM Corporation (Truven Health Analytics)
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations